PIPages
Labs

Michael Rosenberg

University of Colorado Denver/Anschutz Medical Campus, CO·Medicine & Clinical Research

Over a hundred medicines in use today can, in rare cases, disturb the heart's electrical recovery between beats. On an electrocardiogram this shows up as a lengthened QT interval, and it can trigger torsade de pointes, a dangerous rhythm disturbance.

Fields

Medicine & Clinical Research

Computer Science

Pharmacology

Topics

QT prolongation

torsade de pointes

drug-induced long QT syndrome

Grants
1 known grant, through Jan 2027

What they work on

  1. Develop and test a cloud-based deep-learning model that predicts risk of drug-induced long QT syndrome from electronic health record data on hospitalized and outpatient patients, without requiring a prior electrocardiogram.
  2. Validate genetic predictors of drug-induced QT prolongation using an institutional biobank and an external multi-ethnic population, applying an aggregate polygenic risk score that sums the effects of many DNA variants.
  3. Genotype participants with a Multi-Ethnic Genotyping Array designed for imputation across non-European ancestries, so that risk prediction holds across diverse patient populations.
  4. Build and evaluate clinical decision support tools that combine the deep-learning and genetic predictions to reduce prescribing of QT-prolonging drugs to at-risk patients, using data mapped to the Observational Medical Outcomes Partnership common data model for portability to other institutions.

More about the research

Because QT-prolonging drugs are prescribed across virtually every medical specialty, often for conditions unrelated to the heart, clinicians need a reliable way to know in advance which patients are at risk. This project builds and tests software that makes that prediction at the moment of prescribing.

Why it matters

Drug-induced QT prolongation is an uncommon but potentially fatal side effect of widely prescribed medications. A tool that flags high-risk patients before a prescription is written could let clinicians choose a safer alternative when one exists, or monitor more closely when it does not. Because the models are built on a shared data format and a multi-ethnic genotyping platform, they are designed to be reusable at other health systems and across ancestry groups, and to serve as a template for decision support in other conditions.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Development of End-To-End Clinical Decision Support Tools To Prevent Cardiotoxic Drug Response

NIH · Feb 2020 – Jan 2027

Closest labs

Jacqueline Stocking

University of California-Davis, CA·Medicine & Clinical Research·Early-career

Optimize and validate an automated, EHR-based model predicting postoperative respiratory failure, using surgical patient data from 2014 to 2021 and pre- and intra-operative risk factors.

Nosheen Reza

University of Pennsylvania, PA·Medicine & Clinical Research·Early-career

Build and validate a machine learning model that detects hypertrophic cardiomyopathy from electrocardiograms in Penn Medicine electronic health record data, and test whether adding other EHR-derived traits improves detection.

Sunny Lou

Washington University in St Louis, MO·Medicine & Clinical Research·Early-career

Embed S-PATH, a personalized AI model that predicts a patient's risk of needing a surgical blood transfusion, into the electronic health record as a clinical decision support tool for presurgical blood orders.

The school

University of Colorado Denver/Anschutz Medical Campus: 41 labs on PI Pages, $766M a year on research, 205 research doctorates a year.

More about University of Colorado Denver/Anschutz Medical Campus

Reach out

A start for your email. Fill in the brackets.